Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionglucosyltransferase activity

ALG5 UGCG PLOD1

6.32e-0522713GO:0046527
GeneOntologyMolecularFunctionRNA strand annealing activity

FXR1 FMR1

1.24e-045712GO:0033592
GeneOntologyBiologicalProcessregulation of translation at presynapse, modulating synaptic transmission

FXR1 FMR1 FXR2

3.74e-083703GO:0099577
GeneOntologyBiologicalProcessregulation of translation at presynapse

FXR1 FMR1 FXR2

3.74e-083703GO:0140244
GeneOntologyBiologicalProcessregulation of translation at synapse, modulating synaptic transmission

FXR1 FMR1 FXR2

3.10e-069703GO:0099547
GeneOntologyBiologicalProcesspositive regulation of long-term neuronal synaptic plasticity

FXR1 FMR1 FXR2

6.06e-0611703GO:0048170
GeneOntologyBiologicalProcessregulation of translation at synapse

FXR1 FMR1 FXR2

1.04e-0513703GO:0140243
GeneOntologyBiologicalProcessRab protein signal transduction

RAB12 RAB21 RAB4A

4.77e-0521703GO:0032482
GeneOntologyBiologicalProcessregulation of long-term synaptic potentiation

FXR1 FMR1 EIF2AK4 HNRNPK

7.93e-0567704GO:1900271
GeneOntologyBiologicalProcesspositive regulation of receptor-mediated endocytosis

FMR1 PARD3 RAB21 HNRNPK

7.93e-0567704GO:0048260
GeneOntologyBiologicalProcessnegative regulation of CREB transcription factor activity

SIK1 EIF2AK4

1.13e-045702GO:0032792
GeneOntologyBiologicalProcessregulation of neuronal synaptic plasticity

FXR1 FMR1 FXR2 KMT2A

1.83e-0483704GO:0048168
GeneOntologyBiologicalProcessperipheral nervous system axon ensheathment

AKT2 PARD3 ADAM22

1.90e-0433703GO:0032292
GeneOntologyBiologicalProcessmyelination in peripheral nervous system

AKT2 PARD3 ADAM22

1.90e-0433703GO:0022011
GeneOntologyBiologicalProcesspositive regulation of long-term synaptic potentiation

FMR1 EIF2AK4 HNRNPK

2.08e-0434703GO:1900273
GeneOntologyBiologicalProcessregulation of long-term neuronal synaptic plasticity

FXR1 FMR1 FXR2

3.38e-0440703GO:0048169
DomainFXMRP1_C_core

FXR1 FMR1 FXR2

4.62e-083683IPR022034
DomainAgenet-like_dom

FXR1 FMR1 FXR2

4.62e-083683IPR008395
DomainAgenet

FXR1 FMR1 FXR2

4.62e-083683PF05641
DomainFXMRP1_C_core

FXR1 FMR1 FXR2

4.62e-083683PF12235
DomainAGENET_LIKE

FXR1 FMR1 FXR2

4.62e-083683PS51641
DomainKH_1

FXR1 FMR1 FXR2 HNRNPK

1.08e-0538684PF00013
Domain-

FXR1 FMR1 FXR2 HNRNPK

1.20e-05396843.30.1370.10
DomainFXR_C1

FXR1 FXR2

1.31e-052682PF16096
DomainFXR_C1

FXR1 FXR2

1.31e-052682IPR032172
DomainKH

FXR1 FMR1 FXR2 HNRNPK

1.33e-0540684SM00322
DomainKH_dom

FXR1 FMR1 FXR2 HNRNPK

1.33e-0540684IPR004087
DomainKH_TYPE_1

FXR1 FMR1 FXR2 HNRNPK

1.62e-0542684PS50084
DomainKH_dom_type_1

FXR1 FMR1 FXR2 HNRNPK

1.95e-0544684IPR004088
DomainPHD

PHF19 KDM5A ASH1L KMT2A

1.61e-0475684PF00628
DomainGasdermin

GSDME GSDMC

1.94e-046682PF04598
DomainZnf_PHD-finger

PHF19 KDM5A ASH1L KMT2A

1.97e-0479684IPR019787
DomainPHD

PHF19 KDM5A ASH1L KMT2A

3.11e-0489684SM00249
DomainZnf_PHD

PHF19 KDM5A ASH1L KMT2A

3.38e-0491684IPR001965
DomainVIT

PARP4 ITIH3

3.61e-048682PF08487
DomainVIT

PARP4 ITIH3

3.61e-048682SM00609
DomainGasdermin

GSDME GSDMC

3.61e-048682IPR007677
DomainZF_PHD_2

PHF19 KDM5A ASH1L KMT2A

3.99e-0495684PS50016
DomainZF_PHD_1

PHF19 KDM5A ASH1L KMT2A

4.15e-0496684PS01359
DomainSET

ASH1L KMT2A SMYD5

4.46e-0441683PF00856
DomainVIT

PARP4 ITIH3

5.77e-0410682PS51468
DomainVIT

PARP4 ITIH3

5.77e-0410682IPR013694
DomainSET

ASH1L KMT2A SMYD5

6.26e-0446683SM00317
DomainSET_dom

ASH1L KMT2A SMYD5

8.00e-0450683IPR001214
DomainSET

ASH1L KMT2A SMYD5

8.00e-0450683PS50280
DomainVWA

PARP4 VIT ITIH3

1.11e-0356683PF00092
DomainPost-SET_dom

ASH1L KMT2A

1.52e-0316682IPR003616
DomainPostSET

ASH1L KMT2A

1.52e-0316682SM00508
DomainPOST_SET

ASH1L KMT2A

1.52e-0316682PS50868
DomainPoly(ADP-ribose)pol_cat_dom

PARP6 PARP4

1.71e-0317682IPR012317
DomainPARP_CATALYTIC

PARP6 PARP4

1.71e-0317682PS51059
DomainPARP

PARP6 PARP4

1.71e-0317682PF00644
Domain-

PARP6 PARP4

1.71e-03176823.90.228.10
DomainZinc_finger_PHD-type_CS

PHF19 KDM5A ASH1L

1.72e-0365683IPR019786
DomainZnf_FYVE_PHD

PHF19 KDM5A ASH1L KMT2A

2.03e-03147684IPR011011
DomainCa/CaM-dep_Ca-dep_prot_Kinase

MARK4 TSSK2 SIK1

2.04e-0369683IPR020636
DomainRAB

RAB12 RAB21 RAB4A

2.39e-0373683PS51419
Domain-

PARP4 VIT ITIH3

2.49e-03746833.40.50.410
DomainProtein_kinase_ATP_BS

MARK4 TSSK2 SIK1 AKT2 ROS1 EIF2AK4

2.55e-03379686IPR017441
DomainBRCT

PARP4 SLF1

2.88e-0322682SM00292
DomainHAD-like_dom

ATP7A ATP2B3 PMM2

3.00e-0379683IPR023214
Domain-

PARP4 SLF1

3.15e-03236823.40.50.10190
DomainVWFA

PARP4 VIT ITIH3

3.33e-0382683PS50234
DomainWGR_domain

PARP6 PARP4

3.42e-0324682IPR008893
DomainNA-bd_OB-fold

FXR1 RPS11 MCM4

3.44e-0383683IPR012340
DomainVWA

PARP4 VIT ITIH3

3.56e-0384683SM00327
DomainBRCT

PARP4 SLF1

4.01e-0326682PS50172
DomainNucleotide-diphossugar_trans

ALG5 UGCG PLOD1

4.06e-0388683IPR029044
DomainAT_hook

ASH1L KMT2A

4.32e-0327682SM00384
DomainAT_hook_DNA-bd_motif

ASH1L KMT2A

4.32e-0327682IPR017956
DomainBRCT_dom

PARP4 SLF1

4.64e-0328682IPR001357
DomainGlycos_transf_2

ALG5 UGCG

5.32e-0330682PF00535
DomainGlyco_trans_2-like

ALG5 UGCG

5.32e-0330682IPR001173
DomainUBA

MARK4 SIK1

5.32e-0330682SM00165
Domain-

RAB12 MCM4 DDX51 MSH3 COASY RAB21 DNA2 RAB4A

5.56e-037466883.40.50.300
DomainVWF_A

PARP4 VIT ITIH3

5.64e-0399683IPR002035
Pubmed

Fragile X-related proteins regulate mammalian circadian behavioral rhythms.

FXR1 FMR1 FXR2

8.15e-09371318589395
Pubmed

Spatial control of nucleoporin condensation by fragile X-related proteins.

FXR1 FMR1 FXR2

8.15e-09371332706158
Pubmed

Trapping of messenger RNA by Fragile X Mental Retardation protein into cytoplasmic granules induces translation repression.

FXR1 FMR1 FXR2

8.15e-09371312417522
Pubmed

The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2.

FXR1 FMR1 FXR2

8.15e-0937137489725
Pubmed

Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them.

FXR1 FMR1 FXR2

8.15e-0937138668200
Pubmed

Sub-synaptic, multiplexed analysis of proteins reveals Fragile X related protein 2 is mislocalized in Fmr1 KO synapses.

FXR1 FMR1 FXR2

8.15e-09371327770568
Pubmed

Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs.

FXR1 FMR1 FXR2

8.15e-09371319487368
Pubmed

Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P.

FXR1 FMR1 FXR2

8.15e-09371320442204
Pubmed

LLPS of FXR proteins drives replication organelle clustering for β-coronaviral proliferation.

FXR1 FMR1 FXR2

8.15e-09371338587486
Pubmed

The fragile X-related proteins FXR1P and FXR2P contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins.

FXR1 FMR1 FXR2

8.15e-09371310888599
Pubmed

Evidence that fragile X mental retardation protein is a negative regulator of translation.

FXR1 FMR1 FXR2

8.15e-09371311157796
Pubmed

Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer.

FXR1 FMR1 FXR2

8.15e-09371332878499
Pubmed

Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes.

FXR1 FMR1 FXR2

8.15e-09371326612855
Pubmed

Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis.

FXR1 FMR1 FXR2

8.15e-0937139259278
Pubmed

Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex.

FXR1 FMR1 FXR2

3.26e-08471310567518
Pubmed

The nuclear microspherule protein 58 is a novel RNA-binding protein that interacts with fragile X mental retardation protein in polyribosomal mRNPs from neurons.

FXR1 FMR1 FXR2

3.26e-08471316571602
Pubmed

Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP.

FXR1 FMR1 FXR2

3.26e-08471318664458
Pubmed

A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein.

FXR1 FMR1 FXR2

3.26e-08471310556305
Pubmed

Defining the membrane proteome of NK cells.

PARP4 DNAJC13 FXR1 ATP7A FMR1 FXR2 ALG5 RPS11 MCM4 DDX51 MSH3 FKBP8 PLEK HNRNPK

8.67e-081168711419946888
Pubmed

A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P.

FXR1 FMR1 FXR2

1.62e-07671311438699
Pubmed

C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions.

FXR1 FMR1 FXR2 RPS11

2.70e-072771429420262
Pubmed

Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step.

FXR1 FXR2 HNRNPK

4.53e-07871323974796
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

FXR1 FMR1 RRP1B KDM5A FXR2 KMT2A ROS1 EIF2AK4 PARD3 RAB21 PLOD1 ITIH3 HP1BP3 TFPI

6.01e-071371711436244648
Pubmed

Fragile X related protein 1 clusters with ribosomes and messenger RNAs at a subset of dendritic spines in the mouse hippocampus.

FXR1 FMR1 FXR2

1.33e-061171322022532
Pubmed

FXR1P but not FMRP regulates the levels of mammalian brain-specific microRNA-9 and microRNA-124.

FXR1 FMR1 FXR2

1.33e-061171321957233
Pubmed

Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma.

FXR1 FMR1 FXR2

1.33e-061171329142209
Pubmed

Dynamic patterns of histone H3 lysine 4 methyltransferases and demethylases during mouse preimplantation development.

KDM5A ASH1L KMT2A

2.30e-061371324619213
Pubmed

CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.

PARP4 DNAJC13 RRP1B FXR2 MCM4 FKBP8 RAB21 DNA2 PLOD1

3.98e-0660671936538041
Pubmed

The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses.

FXR1 FMR1

4.11e-06271212581522
Pubmed

The RNA-binding protein fragile X-related 1 regulates somite formation in Xenopus laevis.

FXR1 FMR1

4.11e-06271216000371
Pubmed

Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2.

FXR1 FXR2

4.11e-06271211735223
Pubmed

Highly conserved 3' UTR and expression pattern of FXR1 points to a divergent gene regulation of FXR1 and FMR1.

FXR1 FMR1

4.11e-0627128634689
Pubmed

Deficient Sleep in Mouse Models of Fragile X Syndrome.

FMR1 FXR2

4.11e-06271228919851
Pubmed

On the aggregation properties of FMRP--a link with the FXTAS syndrome?

FMR1 FXR2

4.11e-06271221446998
Pubmed

Mutsβ generates both expansions and contractions in a mouse model of the Fragile X-associated disorders.

FMR1 MSH3

4.11e-06271226420841
Pubmed

Dicer-derived microRNAs are utilized by the fragile X mental retardation protein for assembly on target RNAs.

FXR1 FMR1

4.11e-06271217057366
Pubmed

Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models.

FMR1 FXR2

4.11e-06271219244359
Pubmed

The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits.

FMR1 FXR2

4.11e-06271219193898
Pubmed

FXR1, an autosomal homolog of the fragile X mental retardation gene.

FXR1 FMR1

4.11e-0627127781595
Pubmed

Structural studies of the tandem Tudor domains of fragile X mental retardation related proteins FXR1 and FXR2.

FXR1 FXR2

4.11e-06271221072162
Pubmed

Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P.

FXR1 FMR1

4.11e-06271210527928
Pubmed

Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations.

FXR1 FXR2

4.11e-06271210196376
Pubmed

Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.

FMR1 FXR2

4.11e-06271216675531
Pubmed

The Fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice.

FMR1 FXR2

4.11e-06271225552647
Pubmed

WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.

DNAJC13 FXR1 FMR1 RRP1B FXR2 RPS11 PLOD1 HNRNPK HP1BP3

4.48e-0661571931048545
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

FXR1 FMR1 RRP1B FXR2 KMT2A MCM4 DDX51 PLOD1 HP1BP3

7.25e-0665371922586326
Pubmed

The association of UBAP2L and G3BP1 mediated by small nucleolar RNA is essential for stress granule formation.

FXR1 FMR1 FXR2

1.06e-052171337059803
Pubmed

Transport kinetics of FMRP containing the I304N mutation of severe fragile X syndrome in neurites of living rat PC12 cells.

FXR1 FMR1

1.23e-05371215380484
Pubmed

Akt2 deficiency promotes cardiac induction of Rab4a and myocardial β-adrenergic hypersensitivity.

AKT2 RAB4A

1.23e-05371220728450
Pubmed

miR-142-3p down-regulation contributes to thyroid follicular tumorigenesis by targeting ASH1L and MLL1.

ASH1L KMT2A

1.23e-05371225238203
Pubmed

Fragile X Proteins FMRP and FXR2P Control Synaptic GluA1 Expression and Neuronal Maturation via Distinct Mechanisms.

FMR1 FXR2

1.23e-05371226051932
Pubmed

FXR1 regulates transcription and is required for growth of human cancer cells with TP53/FXR2 homozygous deletion.

FXR1 FXR2

1.23e-05371228767039
Pubmed

Differential regulation of Akt/protein kinase B isoforms during cell cycle progression.

AKT2 PARD3

1.23e-05371219166849
Pubmed

FXR2P Exerts a Positive Translational Control and Is Required for the Activity-Dependent Increase of PSD95 Expression.

FMR1 FXR2

1.23e-05371226109663
Pubmed

FMRP, FXR1 protein and Dlg4 mRNA, which are associated with fragile X syndrome, are involved in the ubiquitin-proteasome system.

FXR1 FMR1

1.23e-05371236732356
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

FXR1 RRP1B KDM5A FXR2 ALG5 RPS11 KMT2A MCM4 RAB21 PLOD1 HNRNPK HP1BP3

1.35e-051318711230463901
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

SPAM1 FXR1 FMR1 KDM5A FXR2 MARK4 ASH1L QTRT2 FKBP8 PARD3 DNA2

1.55e-051116711131753913
Pubmed

Fragile X related protein 1 (FXR1P) regulates proliferation of adult neural stem cells.

FXR1 FXR2

2.46e-05471228204491
Pubmed

Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translation.

FXR1 HNRNPK

2.46e-05471236329064
Pubmed

KDM5A noncanonically binds antagonists MLL1/2 to mediate gene regulation and promotes epithelial to mesenchymal transition.

KDM5A KMT2A

2.46e-05471237722486
Pubmed

Gasdermin D is the only Gasdermin that provides protection against acute Salmonella gut infection in mice.

GSDME GSDMC

2.46e-05471237988464
Pubmed

The nuclear protein PH5P of the inter-alpha-inhibitor superfamily: a missing link between poly(ADP-ribose)polymerase and the inter-alpha-inhibitor family and a novel actor of DNA repair?

PARP4 ITIH3

2.46e-05471210100603
Pubmed

Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.

DNAJC13 FXR1 FMR1 RRP1B FXR2 RPS11 HNRNPK

2.47e-0542171734650049
Pubmed

Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.

FXR1 FMR1 FXR2 MARK4 FKBP8 PARD3 ADAM22

2.83e-0543071732581705
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

DNAJC13 ATP7A RPS11 FKBP8 PARD3 RAB21 HNRNPK HP1BP3 SH3BP4

2.86e-0577771935844135
Pubmed

SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers.

FXR1 FMR1 FXR2 RPS11 HNRNPK

2.87e-0517371523979707
Pubmed

FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.

DNAJC13 FXR1 FMR1 RRP1B RPS11 KMT2A EIF2AK4 HP1BP3

3.10e-0560171833658012
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

FMR1 RRP1B FXR2 RPS11 KMT2A DDX51 HNRNPK HP1BP3

3.25e-0560571828977666
Pubmed

Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.

FXR1 FMR1 RRP1B FXR2 RPS11 HNRNPK HP1BP3

3.32e-0544171731239290
Pubmed

EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.

DNAJC13 FXR1 RPS11 MCM4 FKBP8 RAB21 PLOD1 HNRNPK HP1BP3

3.70e-0580371936517590
Pubmed

Large-scale proteomics and phosphoproteomics of urinary exosomes.

SNF8 PARP4 DNAJC13 SLC12A1 RPS11 COASY SAT2 RAB21 PLOD1 SH3BP4

3.98e-051016711019056867
Pubmed

Novel FMRP interaction networks linked to cellular stress.

FXR1 FMR1

4.09e-05571232525608
Pubmed

SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.

FXR1 FMR1 RRP1B FXR2 RPS11 COASY HNRNPK

4.52e-0546371734901782
Pubmed

A protein interaction landscape of breast cancer.

FXR1 FMR1 PHF19 FXR2 AKT2 MSH3 PLOD1 HP1BP3

4.52e-0563471834591612
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

CRYBG2 FXR1 FMR1 PHF19 KMT2A MCM4 DNA2

4.90e-0546971727634302
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

PARP4 FMR1 KMT2A EIF2AK4 FKBP8 DNA2 HP1BP3 SH3BP4

5.39e-0565071838777146
Pubmed

Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

DNAJC13 FXR1 FMR1 RRP1B FXR2 RPS11 KMT2A DDX51 HP1BP3

5.58e-0584771935850772
Pubmed

Identification of Human Neuronal Protein Complexes Reveals Biochemical Activities and Convergent Mechanisms of Action in Autism Spectrum Disorders.

FXR1 FMR1 FXR2 MCM4

5.61e-0510171426949739
Pubmed

SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.

FXR1 FMR1 RRP1B FXR2 RPS11 PLOD1 HNRNPK HP1BP3

5.68e-0565571835819319
Pubmed

ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.

FXR1 FMR1 RRP1B FXR2 MSH3 PLOD1 HP1BP3 TFPI

5.99e-0566071832780723
Pubmed

Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells.

ASH1L KMT2A

6.13e-05671225866973
Pubmed

Wdr1-mediated cell shape dynamics and cortical tension are essential for epidermal planar cell polarity.

CELSR1 PARD3

6.13e-05671225915128
Pubmed

Akt2 (Protein Kinase B Beta) Stabilizes ATP7A, a Copper Transporter for Extracellular Superoxide Dismutase, in Vascular Smooth Muscle: Novel Mechanism to Limit Endothelial Dysfunction in Type 2 Diabetes Mellitus.

ATP7A AKT2

6.13e-05671229301787
Pubmed

Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.

FXR1 FMR1 RRP1B FXR2 DDX51 HP1BP3

6.15e-0533271625693804
Pubmed

Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.

RRP1B KMT2A MCM4 HP1BP3

6.28e-0510471426167872
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

FXR1 KDM5A MARK4 TSSK2 KMT2A SIK1 PARD3 RAB21 SH3BP4

6.32e-0586171936931259
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

PARP4 GSDME FMR1 KDM5A BTBD1 PARD3 HNRNPK

7.05e-0549771723414517
Pubmed

Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1.

PARP4 RRP1B TTLL1

8.22e-05417138724849
Pubmed

KAP1 facilitates reinstatement of heterochromatin after DNA replication.

FXR1 ALG5 RPS11 MCM4 MSH3 RAB21 HNRNPK PMM2

9.38e-0570471829955894
Pubmed

TRIM65 regulates microRNA activity by ubiquitination of TNRC6.

FXR1 FMR1 RRP1B FXR2 DNA2 HP1BP3

1.02e-0436471624778252
Pubmed

RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.

FXR1 FMR1 RRP1B FXR2 RPS11 PLOD1 HNRNPK HP1BP3

1.02e-0471371829802200
Pubmed

Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.

RRP1B RPS11 ASH1L KMT2A MSH3 HNRNPK HP1BP3

1.09e-0453371730554943
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

PARP4 DNAJC13 FXR1 FMR1 KDM5A FXR2 PLOD1 HNRNPK

1.14e-0472471836232890
Pubmed

Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.

ASH1L KMT2A

1.14e-04871223130995
Pubmed

Plakophilins 1 and 3 bind to FXR1 and thereby influence the mRNA stability of desmosomal proteins.

FXR1 FMR1

1.14e-04871225225333
Pubmed

Tissue and developmental regulation of fragile X mental retardation 1 exon 12 and 15 isoforms.

FMR1 UGCG

1.14e-04871219362146
Pubmed

Using brain cell-type-specific protein interactomes to interpret neurodevelopmental genetic signals in schizophrenia.

FXR1 FMR1 BTBD1

1.16e-044671337207277
Pubmed

TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.

FXR1 FMR1 RRP1B FXR2 RPS11 MCM4 DDX51 HNRNPK HP1BP3

1.32e-0494971936574265
Pubmed

Structural basis of family-wide Rab GTPase recognition by rabenosyn-5.

RAB21 RAB4A

1.47e-04971216034420
Pubmed

SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.

FXR1 FMR1 RRP1B HNRNPK HP1BP3

1.48e-0424571535652658
GeneFamilyPHD finger proteins

PHF19 KDM5A ASH1L KMT2A

8.69e-059047488
GeneFamilyRAB, member RAS oncogene GTPases

RAB12 RAB21 RAB4A

6.42e-0465473388
GeneFamilyZinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases

PARP6 PARP4

8.77e-0417472684
GeneFamilyZinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family

ASH1L KMT2A

3.52e-0334472487
CoexpressionGSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP

ATP7A RRP1B NBEAL1 ALG5 QTRT2 DDX51 EIF2AK4

6.11e-07181717M6849
CoexpressionGOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN

RRP1B SURF2 ASH1L DDX51 EIF2AK4 ADAM22

1.74e-05200716M3044
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA4D PARP4 CELSR1 DNAH17 AKT2 PARD3

4.80e-0718371692fbd83a9d13ee91065cbd479fb298f1fd564568
Drug4-aminohexanoic Acid

FXR1 FMR1 FXR2 SPIC

2.57e-0718714CID000138490
DrugVAI2

FXR1 FMR1 FXR2 HNRNPK TFPI PMM2

5.86e-0797716CID003474204
DrugICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A

TEX261 GSDME PDE8B TTLL1 FKBP8 PARD3 ADAM22

2.45e-061947171146_UP
DrugPhenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A

PDE8B DNAH17 KMT2A AKT2 FKBP8 ADAM22 TFPI

2.72e-061977176105_DN
DrugGW8510; Up 200; 10uM; PC3; HT_HG-U133A

GABRR2 SPAM1 PDE8B UGCG SIK1 FKBP8

2.53e-051867167067_UP
Drug0173570-0000 [211245-44-2]; Down 200; 10uM; MCF7; HT_HG-U133A

TEX261 MARK4 UGCG AKT2 ADAM22 TFPI

3.30e-051957164712_DN
DrugVerapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HG-U133A

DNAJC13 FMR1 UGCG SIK1 MSH3 TFPI

3.30e-051957161927_UP
DrugFluspirilen [1841-19-6]; Down 200; 8.4uM; PC3; HT_HG-U133A

TEX261 SEMA4D RRP1B MARK4 TSSK2 TTLL1

3.30e-051957166662_DN
Drugnovobiocin sodium, USP; Down 200; 100uM; SKMEL5; HG-U133A

ASH1L MCM4 MSH3 FKBP8 PARD3 HP1BP3

3.30e-05195716632_DN
DrugProgesterone [57-83-0]; Up 200; 12.8uM; PC3; HT_HG-U133A

SPAM1 PDE8B PLCH2 KMT2A ATP2B3 ADAM22

3.39e-051967166646_UP
DrugRiluzole hydrochloride; Up 200; 14.8uM; HL60; HT_HG-U133A

TEX261 GSDME KDM5A MARK4 KMT2A ADAM22

3.49e-051977162334_UP
DrugTocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; HL60; HT_HG-U133A

DNAJC13 GSDME RRP1B UGCG TTLL1 FKBP8

3.59e-051987161320_UP
DrugSulfanilamide [63-74-1]; Up 200; 23.2uM; MCF7; HT_HG-U133A

GABRR2 SPAM1 KMT2A AKT2 FKBP8 ADAM22

3.69e-051997163449_UP
DrugCefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; PC3; HT_HG-U133A

TEX261 GABRR2 FXR2 PLCH2 AKT2 TTLL1

3.69e-051997164067_UP
Drug(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; PC3; HT_HG-U133A

SPAM1 PDE8B MARK4 TTLL1 ATP2B3 ADAM22

3.69e-051997164016_DN
DrugPralidoxime chloride [51-15-0]; Up 200; 23.2uM; PC3; HT_HG-U133A

PARP6 CRYBG2 FXR2 UGCG FKBP8 ADAM22

3.80e-052007166283_UP
DrugAC1NB8R3

FXR1 FMR1 FXR2 KMT2A HNRNPK TFPI

5.39e-05213716CID004489307
Drugtrimethoprim-sulfamethoxazole

FXR1 FMR1 FXR2 HNRNPK

5.41e-0566714CID000358641
Diseasemalignant pleural mesothelioma (implicated_via_orthology)

FXR1 FMR1 FXR2

1.22e-083693DOID:7474 (implicated_via_orthology)
Diseasefragile X syndrome (implicated_via_orthology)

FXR1 FMR1 FXR2

1.22e-083693DOID:14261 (implicated_via_orthology)
Diseaseautism spectrum disorder (implicated_via_orthology)

FXR1 FMR1 KDM5A FXR2 ASH1L

2.93e-05152695DOID:0060041 (implicated_via_orthology)
Diseasediamine acetyltransferase 2 measurement

FXR2 SAT2

8.03e-056692EFO_0802465
Diseasepneumococcal meningitis

CELSR1 ROS1

1.50e-048692EFO_1001114
DiseaseNEURAL TUBE DEFECTS, SUSCEPTIBILITY TO

CELSR1 PARD3

1.50e-048692C3891448
DiseaseHDL cholesterol change measurement, response to simvastatin, response to fenofibrate

CELSR1 MSH3

1.50e-048692EFO_0007805, GO_1901557, GO_1903491
Diseaseblood nickel measurement

SLC12A1 UGCG PLEK GSDMC

1.83e-04120694EFO_0007583
Diseasedevelopmental disorder of mental health (implicated_via_orthology)

GABRR2 ASH1L PARD3

2.09e-0449693DOID:0060037 (implicated_via_orthology)
Diseasecongenital disorder of glycosylation type I (implicated_via_orthology)

ALG5 PMM2

5.55e-0415692DOID:0050570 (implicated_via_orthology)
Diseasepentachlorophenol measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022071
Diseaseparathion measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022070
Diseasepotassium chromate measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022072
Diseasemercuric chloride measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022068
Diseaseheptachlor epoxide measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022067
Diseasemethoxychlor measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022069
Disease4,6-dinitro-o-cresol measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022053
Disease2,4,5-trichlorophenol measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022052
Diseaseazinphos methyl measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022055
Diseasealdrin measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022054
Diseasedicofol measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022060
Diseasedisulfoton measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022062
Diseasedieldrin measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022061
Diseaseendrin measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022064
Diseaseendosulfan measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022063
Diseaseheptachlor measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022066
Diseaseethion measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022065
Diseasechlorpyrifos measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022057
Diseasecadmium chloride measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022056
Diseasediazinon measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022059
Diseasedibutyl phthalate measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0022058
Diseaseenvironmental exposure measurement

UGCG PLEK GSDMC

6.77e-0473693EFO_0008360
DiseaseDDT metabolite measurement

UGCG PLEK GSDMC

7.04e-0474693EFO_0007886
DiseaseAbnormality of refraction

SEMA4D DNAJC13 PHF19 RRP1B KDM5A PLCH2 PARD3

9.87e-04673697HP_0000539
DiseaseAdenocarcinoma of large intestine

MARK4 AKT2 ROS1

1.50e-0396693C1319315
Diseaseblood cobalt measurement

UGCG PLEK GSDMC

1.73e-03101693EFO_0007577
Diseasecerebral white matter volume change measurement, age at assessment

KMT2A VIT

1.96e-0328692EFO_0008007, EFO_0021499

Protein segments in the cluster

PeptideGeneStartEntry
IPGVGGKTRLEKQFK

PTPRG

1141

P23470
KLLGKGTFGKVILVR

AKT2

156

P31751
QKNKVGERKGLVSRG

FAM228A

171

Q86W67
GKKLGLGTVVGLVNK

ASH1L

356

Q9NR48
LGKGAFGAVIKVQNK

EIF2AK4

596

Q9P2K8
KVRVITLVKNRGKGG

ALG5

131

Q9Y673
GQGQGESLRVKKKAL

GSDMC

191

Q9BYG8
LLRGKQGGFENKKRI

GSDME

236

O60443
QGNLGGNKKKIRGKR

ADAM22

836

Q9P0K1
QEVRKHLKGVLGGRK

CELSR1

2706

Q9NYQ6
QGKLTKLAVQIGKAG

ATP2B3

361

Q16720
GKIGKLQGVQRIKVS

ATP7A

191

Q04656
LNRGVIKQVKGKGAS

HP1BP3

211

Q5SSJ5
TLGIANKGGKRKQLY

NBEAL1

606

Q6ZS30
FKLQVIIIGSRGVGK

RAB12

41

Q6IQ22
FLTKKLNIGGKRVNL

RAB21

56

Q9UL25
GSKIINVGGKYVKLQ

RAB4A

51

P20338
SKKFKILIEGVLGQG

MAMDC2

136

Q7Z304
IKKGILLQLFGGTRK

MCM4

476

P33991
KKKGNIFIGIVGVQP

MSH3

381

P20585
NLVGKVIGKNGKVIQ

FXR2

301

P51116
NLVGKVIGKNGKVIQ

FXR1

291

P51114
GQGGKIRHFVSLKKL

PDE8B

366

O95263
FLKQKGIQSLGVKGR

PARP4

1606

Q9UKK3
LKKLQIFGAGPKVVG

KDM5A

236

P29375
SAGGGQKVRLLKKAL

PLOD1

71

Q02809
TKVVNGCRLGKIKNL

QTRT2

6

Q9H974
IKALFRKGKVLAQQG

FKBP8

306

Q14318
NLVGKVIGKNGKLIQ

FMR1

291

Q06787
LGRNTIKKGKYIKIG

DNAH17

3501

Q9UFH2
LVLGGFGKRKAPKVQ

DDX51

161

Q8N8A6
FGNKQKVLGKALSLI

BTBD1

261

Q9H0C5
KTQGKLNTRPGKVIF

CRYBG2

976

Q8N1P7
RLFIGGKKVGINPKI

UGCG

111

Q16739
GVKVVKALKRSNNGI

DNAJC13

456

O75165
LLRTIGKGNFAKVKL

MARK4

61

Q96L34
KTGKLQIGRKGVQIV

KMT2A

286

Q03164
AIQLEKGGKFTVRGK

SPAM1

406

P38567
KFKIGFLRLGQIQKV

DNA2

691

P51530
RGQGIGSKIIKKVAE

SAT2

101

Q96F10
RKKGLLKGQTGFRIF

GABRR2

421

P28476
KEGFGLGLQLKKILG

PARP6

121

Q2NL67
IGKRLNIQLKKGTEG

PARD3

456

Q8TEW0
FLQKLRQKIKIGVVG

PMM2

31

O15305
IFQNKKRVLLGETGK

RPS11

16

P62280
GGAQLLKRKRKLGVV

RRP1B

516

Q14684
AKVVRGFQLKLGKVS

SH3BP4

556

Q9P0V3
QGKTAGLVKASGRKL

ITIH3

121

Q06033
FRGVIIKQGCLLKQG

PLEK

241

P08567
AVIGKGGKNIKALRT

HNRNPK

56

P61978
TKGFLGLNKIKGLAR

SIK1B

596

A0A0B4J2F2
TKGFLGLNKIKGLAR

SIK1

596

P57059
GIRGLFKKAGKLNIT

SLC12A1

856

Q13621
RGLVQKRGKKQLGSL

SURF2

221

Q15527
VCKGDQGGLRTLQKK

SEMA4D

256

Q92854
QQKGGKGRKKLRLFE

SPIC

101

Q8N5J4
RAIKKLKALGTGFGI

SNF8

146

Q96H20
INRKVLGSRVFGNKK

COASY

421

Q13057
LGSRVFGNKKQLKIL

COASY

426

Q13057
GKVKQALGLKGLFLR

PLCH2

886

O75038
VLGFTGGKLIQRKKQ

STX17

266

P56962
KILVRKVAGQSGYKG

VIT

101

Q6UXI7
KGGALKKGAIARTLQ

PHF19

156

Q5T6S3
KKGNGAIVSQVKALR

ROS1

1411

P08922
FTKGKRGKRLGILVV

TEX261

166

Q6UWH6
ACKKGFIQRISKGGL

TFPI

266

P10646
FIQRISKGGLIKTKR

TFPI

271

P10646
LGSGKIQVSKKIGQR

SLF1

721

Q9BQI6
GMGRIFKGNLLQKKA

SMIM21

26

Q3B7S5
KREKNVGVFQKSLGL

TOPAZ1

1076

Q8N9V7
SVGIQAKVKAFGKRL

THAP10

191

Q9P2Z0
AKGKGLFATQLIRKG

SMYD5

31

Q6GMV2
VLRKKGYIVGINLGK

TSSK2

6

Q96PF2
GKAQGKGIFLINKLS

TTLL1

141

O95922